Identification of receptors for type-beta transforming growth factor.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Methods in Enzymology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 2891018
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes

  1985cited by this paper
• Cellular receptors for type beta transforming growth factor. Ligand binding and affinity labeling in human and rodent cell lines.

  1985cited by this paper
• Stimulation by insulin-like growth factors is required for cellular transformation by type beta transforming growth factor.

  1985cited by this paper
• Methods for studying the platelet-derived growth factor receptor.

  1985cited by this paper
• Characterization of a membrane receptor for transforming growth factor-beta in normal rat kidney fibroblasts.

  1984cited by this paper
• Evidence for the platelet-derived growth factor-stimulated tyrosine phosphorylation of the platelet-derived growth factor receptor in vivo. Immunopurification using a monoclonal antibody to phosphotyrosine.

  1984cited by this paper
• Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells

  1984cited by this paper
• Use of the heterobifunctional cross-linker m-maleimidobenzoyl N-hydroxysuccinimide ester to affinity label cholecystokinin binding proteins on rat pancreatic plasma membranes.

  1984cited by this paper
• Purification and properties of a type beta transforming growth factor from bovine kidney.

  1983cited by this paper
• Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization.

  1983cited by this paper
• Epidermal growth factor-like transforming growth factor. I. Isolation, chemical characterization, and potentiation by other transforming factors from feline sarcoma virus-transformed rat cells.

  1983cited by this paper
• A native 170,000 epidermal growth factor receptor-kinase complex from shed plasma membrane vesicles.

  1982cited by this paper
• Affinity labeling of a transforming growth factor receptor that does not interact with epidermal growth factor.

  1982cited by this paper
• Purification and properties of the human placental insulin receptor.

  1981cited by this paper
• Identification of a nerve growth factor receptor protein in sympathetic ganglia membranes by affinity labeling.

  1981cited by this paper
• Identification of the glucagon receptor in rat liver membranes by photoaffinity crosslinking.

  1981cited by this paper
• Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons.

  1979cited by this paper

• Molecular Mechanism of Pancreatic Stellate Cells Activation in Chronic Pancreatitis and Pancreatic Cancer

  2020cites this paper
• NEDD4-family E3 ligase dysfunction due to PKHD1/Pkhd1 defects suggests a mechanistic model for ARPKD pathobiology

  2017cites this paper
• Proteolytic control of TGF-β co-receptor activity by BMP-1/tolloid-like proteases revealed by quantitative iTRAQ proteomics

  2014cites this paper
• Proteins on the catwalk: modelling the structural domains of the CCN family of proteins

  2009cites this paper
• Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.

  2008cites this paper
• The CCN family of proteins: structure–function relationships

  2008cites this paper
• Extracellular matrix and growth factors in the pathogenesis of some craniofacial malformations.

  2007cites this paper
• Methods for identifying novel integrin ligands.

  2007cites this paper
• Unique human CD133+ leukemia cell line and its modulation towards a mesenchymal phenotype by FGF2 and TGFβ1

  2006cites this paper
• Retinoic Acid, GABA-ergic, and TGF-β Signaling Systems Are Involved in Human Cleft Palate Fibroblast Phenotype

  2006cites this paper
• Three key residues underlie the differential affinity of the TGFbeta isoforms for the TGFbeta type II receptor.

  2006cites this paper
• Role of Transforming Growth Factor ßin the Proliferative Effect of 2,3,7,8-Tetrachlorodibenzo-/>-dioxin on Human Squamous Carcinoma Cells

  2006cites this paper
• Identification and Partial Characterization of TGF-Receptors on Trabecular Cells

  2005cites this paper
• Interleukin-6 regulation of transforming growth factor (TGF)-beta receptor compartmentalization and turnover enhances TGF-beta1 signaling.

  2005cites this paper
• Hyaluronan Regulates Transforming Growth Factor-β1 Receptor Compartmentalization*

  2004cites this paper
• Ursolic acid, an antagonist for transforming growth factor (TGF)‐β1

  2004cites this paper
• TGFp Signals through a Heteromeric Protein Kinase Receptor Complex

  2003cites this paper
• Effect of Transforming Growth Factor-beta (TGF-) on Mammary Development

  2003cites this paper
• In vitro TGF-beta1 antagonistic activity of ursolic and oleanolic acids isolated from Clerodendranthus spicatus.

  2003cites this paper
• Connective-tissue growth factor (CTGF) modulates cell signalling by BMP and TGF-beta.

  2002cites this paper
• Matrix GLA Protein, a Regulatory Protein for Bone Morphogenetic Protein-2*

  2002cites this paper
• Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.

  2002cites this paper
• Effects of transforming growth factor-beta1 and tumour necrosis factor-alpha on cultured fibroblasts from skin fibroma as modulated by toremifene.

  2002cites this paper
• Responsiveness to transforming growth factor-beta (TGF-beta)-mediated growth inhibition is a function of membrane-bound TGF-beta type II receptor in human breast cancer cells.

  2001cites this paper
• Synthesis and Secretion of Transforming Growth Factor-β1 by Human Desmoid Fibroblast Cell Line and Its Modulation by Toremifene

  2001cites this paper
• Transforming growth factor‐β suppresses tumor necrosis factor α‐induced matrix metalloproteinase‐9 expression in monocytes

  2001cites this paper
• Increased Cell Surface Expression of Receptors for Transforming Growth Factor-β on Osteoblasts from Patients with Osteogenesis imperfecta

  2000cites this paper
• Age-related differences in the expression of receptors for TGF-beta in human osteoblast-like cells in vitro.

  2000cites this paper
• Characterization of the inhibition of DNA synthesis in proliferating mink lung epithelial cells by insulin‐like growth factor binding protein‐3

  2000cites this paper
• Modulation of transforming growth factor β response and signaling during transdifferentiation of rat hepatic stellate cells to myofibroblasts

  2000cites this paper
• Identification of tgh-2, a Filarial Nematode Homolog of Caenorhabditis elegans daf-7 and Human Transforming Growth Factor β, Expressed in Microfilarial and Adult Stages of Brugia malayi

  2000cites this paper
• Endoglin Is an Accessory Protein That Interacts with the Signaling Receptor Complex of Multiple Members of the Transforming Growth Factor-β Superfamily*

  1999cites this paper
• EGF , epithelium and TGFb and a influence embryonic fibroblast phenotype 157 TGF β and TGF α , antagonistic effect in vitro on extracellular matrix accumulation by chick skin fibroblasts at two distinct embryonic stages

  1999cites this paper
• TGFbeta and TGFalpha, antagonistic effect in vitro on extracellular matrix accumulation by chick skin fibroblasts at two distinct embryonic stages.

  1999cites this paper
• A transforming growth factor-beta antagonist unmasks the neuroprotective role of this endogenous cytokine in excitotoxic and ischemic brain injury.

  1999cites this paper
• Ligand-induced downregulation of receptors for TGF-beta in human osteoblast-like cells from adult donors.

  1999cites this paper
• Silencing of TGF-beta signalling by the pseudoreceptor BAMBI.

  1999cites this paper
• Expression of normal and truncated forms of human endoglin.

  1999cites this paper
• Inhibition of transforming growth factor-beta/SMAD signalling by the interferon-gamma/STAT pathway.

  1999cites this paper
• Cell-cycle-dependent expression of transforming growth factor beta type I receptor correlates with differential proliferative effects of TGFbeta1 in articular chondrocytes.

  1998cites this paper
• Associations between TGF‐β1 receptors in human bone marrow stromal cells

  1998cites this paper
• Evidence of Type I and Type II Transforming Growth Factor‐β Receptors in Central Nervous Tissues: Changes Induced by Focal Cerebral Ischemia

  1998cites this paper
• Specific Activation of Smad1 Signaling Pathways by the BMP7 Type I Receptor, ALK2*

  1998cites this paper
• Identification of STRAP, a Novel WD Domain Protein in Transforming Growth Factor-β Signaling*

  1998cites this paper
• Phenotypic consequences of transforming growth factor β1 gene ablation in murine embryonic fibroblasts: Autocrine control of cell proliferation and extracellular matrix biosynthesis

  1998cites this paper
• The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF‐β receptors

  1998cites this paper
• Transforming Growth Factor Beta 1 Binding and Receptor Kinetics in Fetal Mouse Lung Fibroblasts

  1998cites this paper
• Use of chlorotoxin for targeting of primary brain tumors.

  1998cites this paper
• Transfection of the type II TGF-beta receptor into colon cancer cells increases receptor expression, inhibits cell growth, and reduces the malignant phenotype.

  1998cites this paper
• Endoglin, a component of the TGF‐β receptor system, is a differentiation marker of human choriocarcinoma cells

  1998cites this paper
• Cell-associated activation of latent transforming growth factor-beta by calpain.

  1998cites this paper
• Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative.

  1997cites this paper
• Mechanism of TGFβ receptor inhibition by FKBP12

  1997cites this paper
• BMP-2 and OP-1 exert direct and opposite effects on renal branching morphogenesis.

  1997cites this paper
• A chimeric serine/threonine kinase receptor system reveals the potential of multiple type II receptors to cooperate with transforming growth factor-beta type I receptor.

  1997cites this paper
• Single exposures to antiproliferatives: long-term effects on ocular fibroblast wound-healing behavior.

  1997cites this paper
• Cloning and characterization of goldfish activin type IIB receptor.

  1997cites this paper
• Complementation between kinase‐defective and activation‐defective TGF‐beta receptors reveals a novel form of receptor cooperativity essential for signaling.

  1996cites this paper
• Endoglin is a component of the transforming growth factor (TGF)-beta receptor complex of human pre-B leukemic cells.

  1996cites this paper
• Endoglin modulates cellular responses to TGF-beta 1

  1996cites this paper
• Expression and structural features of endoglin (CD105), a transforming growth factor beta1 and beta3 binding protein, in human melanoma.

  1996cites this paper
• Dorsoventral patterning in Xenopus: inhibition of ventral signals by direct binding of chordin to BMP-4.

  1996influential citation
• The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4.

  1996cites this paper
• Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.

  1996cites this paper
• Betaglycan has multiple binding sites for transforming growth factor-beta 1.

  1996cites this paper
• A Novel Type I Receptor Serine-Threonine Kinase Predominantly Expressed in the Adult Central Nervous System*

  1996cites this paper
• [TGF-beta: usage in nephrology].

  1996cites this paper
• RRR-alpha-tocopheryl succinate enhances TGF-beta 1, -beta 2, and -beta 3 and TGF-beta R-II expression by human MDA-MB-435 breast cancer cells.

  1996cites this paper
• Involvement of transforming growth factor beta1 in autocrine enhancement of gelatinase B secretion by murine metastatic colon carcinoma cells.

  1996cites this paper
• The unglycosylated extracellular domain of type-II receptor for transforming growth factor-beta. A novel assay for characterizing ligand affinity and specificity.

  1996cites this paper
• Transforming growth factor-beta is a survival factor for neonate cortical neurons: coincident expression of type I receptors in developing cerebral cortices.

  1996cites this paper
• Characterization of TGF-beta 1-binding proteins in human bone marrow stromal cells.

  1996cites this paper
• Transforming growth factor beta regulates differentiation and proliferation of human neuroblastoma.

  1996cites this paper
• Negative regulation of cell growth by TGF beta.

  1996cites this paper
• Cellular and molecular basis of wound healing : effects of growth arrest induced by antimetabolites on ocular fibroblast behaviour.

  1996cites this paper
• Characterization of TGF‐β1‐binding proteins in human bone marrow stromal cells

  1996influential citation
• Discordant regulation of transforming growth factor-beta receptors by prostaglandin E2.

  1995cites this paper
• Transforming growth factor-beta: possible roles in Dupuytren's contracture.

  1995cites this paper
• Characterization of binding of transforming growth factor-beta 1 to bovine mammary membranes.

  1995cites this paper
• Tenascin-C induction in Whitlock-Witte culture: a relevant role of the thiol moiety in lymphoid-lineage differentiation.

  1995cites this paper
• Trypanosome invasion of mammalian cells requires activation of the TGF beta signaling pathway.

  1995cites this paper
• Relationship between actions of transforming growth factor (TGF)‐β and cell surface expression of its receptors in clonal osteoblastic cells

  1995cites this paper
• Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs

  1995influential citation
• Transforming growth factor-beta receptor type II expression in the hamster ovary: cellular site(s), biochemical properties, and hormonal regulation.

  1995cites this paper
• Ligand-induced recruitment and phosphorylation of reduced TGF-beta type I receptor.

  1995cites this paper
• Signaling Activity of Homologous and Heterologous Transforming Growth Factor-β Receptor Kinase Complexes (*)

  1995cites this paper
• Epithelial rat thyroid cell clones, escaping from transforming growth factor beta negative growth control, are still inhibited by this factor in the ability to trap iodide.

  1995cites this paper
• Colon cancer cells that are not growth inhibited by TGF-beta lack functional type I and type II TGF-beta receptors.

  1995cites this paper
• Transforming growth factor beta 1 induces differentiation-specific gene expression in fetal rat brown adipocytes.

  1995cites this paper
• Disruption of transforming growth factor beta signaling by a mutation that prevents transphosphorylation within the receptor complex

  1995cites this paper
• Regulation of transforming growth factor alpha gene expression in an ovarian surface epithelial cell line derived from a human carcinoma.

  1995cites this paper
• J Massagué receptor model to the BMPs . proteins ( BMPs ) : extension of the two-kinase Human type II receptor for bone morphogenic

  1995cites this paper
• Bone morphogenetic protein-9 binds to liver cells and stimulates proliferation.

  1995cites this paper
• TGF beta 1 and TGF beta 2 are potential growth regulators for medulloblastomas, primitive neuroectodermal tumors, and ependymomas: evidence in support of an autocrine hypothesis.

  1994cites this paper
• Interactions between collagen-binding stress protein HSP47 and collagen. Analysis of kinetic parameters by surface plasmon resonance biosensor.

  1994cites this paper
• Absence of transforming growth factor-beta responsiveness in the tamoxifen growth-inhibited human breast cancer cell line CAMA-1.

  1994cites this paper
• Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor beta.

  1994cites this paper
• Plasmin cleaves betaglycan and releases a 60 kDa transforming growth factor-beta complex from the cell surface.

  1994cites this paper
• A mammalian serine/threonine kinase receptor specifically binds BMP-2 and BMP-4.

  1994cites this paper
• Bone matrix decorin binds transforming growth factor-beta and enhances its bioactivity.

  1994cites this paper